Safety, Tolerability, and Pharmacodynamics of ABT-122, a TNF- And IL-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With RA

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40319

Related search